Form 8-K - Current report:
SEC Accession No. 0000950170-24-139580
Filing Date
2024-12-23
Accepted
2024-12-23 16:10:06
Documents
11
Period of Report
2024-12-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K bolt-20241223.htm   iXBRL 8-K 37362
  Complete submission text file 0000950170-24-139580.txt   154275

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bolt-20241223.xsd EX-101.SCH 25969
13 EXTRACTED XBRL INSTANCE DOCUMENT bolt-20241223_htm.xml XML 4940
Mailing Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-665-9295
Bolt Biotherapeutics, Inc. (Filer) CIK: 0001641281 (see all company filings)

EIN.: 472804636 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39988 | Film No.: 241573701
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)